Join over 3,700 drug discovery and development professionals worldwide at the 25th International Molecular Medicine Tri-Conference!
Since its debut in 1993, the annual Molecular Medicine Tri-Conference has become one of the world’s leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world.
Spanning five days, the 2018 meeting includes 16 parallel conference tracks, 7 Symposia, and 25 in-depth short courses. New this year are 9 skills-based training programs. Compelling talks, including best practice case studies and joint partner presentations, will feature over 500 of your fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more.
During the Exhibition on Feb 12-14, the i2b2 tranSMART Foundation will be at booth #321. Come by and visit with us and learn what is new at the Foundation. We will be joined by partners Elevada, Axiomedix and Ingentium. Learn more about them as well!